SynthesisDiabetes & vascular disease research

Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors.

Mei Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.